Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Mesoblast Inc patents


Recent patent applications related to Mesoblast Inc. Mesoblast Inc is listed as an Agent/Assignee. Note: Mesoblast Inc may have other listings under different names/spellings. We're not affiliated with Mesoblast Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Mesoblast Inc-related inventors


Methods and apparatus for separating cells from microcarriers

An apparatus for separating cells from microcarriers comprises a chamber having a body and a base. The chamber is configured to receive a mixture comprising cells and microcarriers. ... Mesoblast Inc

Mesenchymal stem cells expressing tnf-alpha receptors

Mesenchymal stem cells which express tnf-α receptor type i in an amount of at least 13 pg/106 cells. Such mesenchymal stem cells inhibit the proliferation of lymphocytes and may be employed, in particular, in the treatment of graft-versus-host disease.. ... Mesoblast Inc

Cell culture method for mesenchymal stem cells

The present disclosure relates to methods, cell culture medium and compositions that promote cell proliferation during fetal bovine serum free cell culture.. . ... Mesoblast Inc

Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase

The present invention relates to the use of tissue non-specific alkaline phosphatase (tnap) as a marker for identifying and/or isolating adult multipotential cells. The present invention also relates to cell populations enriched by methods of the present invention and therapeutic uses of these cells.. ... Mesoblast Inc

Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions

One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.. ... Mesoblast Inc

Prevention of progressive heart failure

The present disclosure relates to methods for preventing progressive heart failure in subjects with persistent left ventricular (lv) dysfunction. Such methods may also be used for treating or preventing progressive heart failure in subjects with a proximal left anterior descending (lad) lesion and persistent left ventricular dysfunction.. ... Mesoblast Inc

Method for treating heart failure

The present disclosure relates to methods for treating or preventing heart failure in subjects with elevated left ventricular end systolic volume (lvesv). In particular, the present disclosure related to methods for treating or preventing heart failure in subjects with a lvesv of greater than 70 ml (>70 ml).. ... Mesoblast Inc

Methods for increasing osteoblastic function

The present disclosure provides methods of increasing osteoblastic function in a subject, the method comprising systemically administering to the subject a population of stem cells and/or progeny thereof and/or soluble factors derived therefrom.. . ... Mesoblast Inc

Treatment of t-cell mediated immune disorders

A method for suppressing t cell activation which comprises contacting a cell population comprising t cells in vitro or ex vivo with an effective amount of stro-1+ cells and/or soluble factors derived therefrom to suppress t cell activation.. . ... Mesoblast Inc

Methods of generating, repairing and/or maintaining connective tissue in vivo

This invention relates to a method for generating, repairing and/or maintaining connective tissue in a subject. In one embodiment, the invention relates to a method for generating, repairing and/or maintaining cartilage tissue in a subject. ... Mesoblast Inc

Methods for treating obesity and/or metabolic syndrome

The present disclosure provides methods of treating or preventing obesity or causing weight loss or treating or preventing metabolic syndrome comprising administering to a subject a population of cells enriched for stro-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.. . ... Mesoblast Inc

Improved stem cell composition

The disclosure provides stem cells which express high levels of angeopoetin-1 (ang1) and methods for their production. Such stem cells may be used in a range of therapeutic application.. ... Mesoblast Inc

Treatment of immune disorders

The present disclosure relates to stem cells which express high levels of angeopoetin-1 (ang1) and uses thereof in inhibiting m1-type macrophage production and treating inflammatory disease such as diabetes.. . ... Mesoblast Inc

Method for treating or preventing a pancreatic dysfunction

The present invention provides a method for improving pancreatic function in a subject in need thereof, the method comprising administering to the subject stro-1+ cells and/or progeny cells thereof and/or soluble factors derived therefrom. The method of the invention is useful for treating and/or preventing and/or delaying the onset or progression of a disorder resulting from or associated with pancreatic dysfunction, e.g., resulting from abnormal endocrine or exocrine function of the pancreas.. ... Mesoblast Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Mesoblast Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Mesoblast Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###